Related Experiment Video
Updated: Jul 21, 2025
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.5K
Metacognition in Schizophrenia Spectrum Disorders-Current Methods and Approaches
Petru Fabian Lungu1, Corina-Miruna Lungu2, Alin Ciobîcă1,3,4
1Faculty of Biology, Biology Department, "Alexandru Ioan Cuza" University, 700506 Iasi, Romania.
Brain Sciences
|July 29, 2023
Summary
Patients with schizophrenia exhibit impaired metacognition, or "thinking about thinking," affecting daily functioning. This impacts work, memory, motivation, and symptom severity in schizophrenia and schizoaffective disorders.
Area of Science:
- Cognitive Neuroscience
- Psychiatry
Background:
- Metacognition, the ability to monitor and control one's own thinking processes, is crucial for cognitive functioning.
- Impairments in metacognition are a recognized core feature in schizophrenia and related disorders.
- Research on metacognition in schizophrenia has expanded significantly, exploring various cognitive domains.
Purpose of the Study:
- To review and synthesize current literature on metacognition in schizophrenia and schizoaffective disorder.
- To analyze existing methods and findings regarding metacognitive abilities in these patient populations.
- To provide insights into the nuances of metacognition within the lived experiences of individuals with schizophrenia or schizoaffective disorder.
Main Methods:
- This study employed a narrative review methodology.
- Literature analysis focused on studies investigating metacognition in schizophrenia and schizoaffective disorder.
- The review examined various metacognitive processes including insight, memory, beliefs, reasoning, and biases.
Main Results:
- Patients diagnosed with schizophrenia demonstrate significantly lower metacognitive abilities compared to controls.
- These metacognitive deficits have a profound and measurable impact on various aspects of patients' lives.
- A strong correlation exists between schizophrenia symptoms and metacognitive functioning.
Conclusions:
- Metacognitive impairment is a central issue in schizophrenia, influencing critical life domains.
- Understanding metacognition is vital for comprehending the functional deficits associated with schizophrenia and schizoaffective disorder.
- Further research into metacognition can inform therapeutic strategies for improving outcomes in these conditions.
Related Concept Videos
01:26Metacognition
206
Metacognition is a conscious process where individuals are aware of their cognitive and executive processes, such as planning before solving a problem or self-monitoring during reading. For instance, a writer may need help with composing a piece. The situation involves a writer who is working on a piece of writing, but while doing so, they realize that something is missing. They notice that their characters lack depth or details. This realization occurs because the writer is reflecting on their...
206
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
748
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
748
01:30Negative and Cognitive Symptoms of Schizophrenia
96
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
96
01:29Psychological and Sociocultural Causes of Schizophrenia
139
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
139
01:17Schizophrenia
139
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
139
01:26Psychosis: Goals of Pharmacotherapy
168
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
168